Recently, anecdotal evidences of efficacy of anti-TNF-α agents as rescue therapy in difficult-to-treat autoimmune hepatitis (AIH) and primary biliary cholangitis (PBC) have been reported [10,11,12] (Table 1). This evidence concerns the gene TNF and autoimmune hepatitis.